BIOLIDICS LIMITED

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022, 2021

In its 2023 reporting, BIOLIDICS LIMITED disclosed greenhouse gas emissions of 74.45 tCO2e/year. By scope: Scope 2: 74.45 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
74.45 tCO2e/year
2023
💧
Water Usage
51.99 m3/year
2023
♻️
Waste
9.2K liters/year
2023
⚙️
Energy Use
178.6K kWh/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.74.45 tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202374.45 tCO2e/year
202278.80 tCO2e

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Organise at least one activity each year to raise awareness among employees on climate change.
  • Maintain zero fatalities and workplace injuries.
  • Maintain zero known cases concerning breaches of customer privacy.
  • Maintain zero product recall.
  • Achieve an average customer satisfaction rating of 80% with the ClearCell® FX1 System.

📅 Medium-term

  • Maintain or reduce GHG emissions intensity by FY2028.
  • Conduct periodic safety audits and inspections.
  • Acknowledge 100% customer feedback/complaints within 7 days.
  • Complete all CAPA investigations and implement proposed CAPA actions within 1 month and 3 months, respectively.
  • Provide regular anti-corruption training to employees.

🔭 Long-term

  • Continue to implement fair employment practices.

🌱 ESG Focus Areas

Economic PerformanceClimate Change Mitigation and AdaptationOccupational Health and SafetyTalent RetentionDiversity, Equal Opportunity and Non-discriminationResearch and Development/InnovationCustomer PrivacyProduct Quality and SafetyAnti-corruptionEnvironmental and Socioeconomic Compliance

⚠️ Challenges & Risks +

  • Decreased revenue due to decreased demand for PCR testing services and intense price competition on ART kits.
  • Weakening liquidity position.
  • Transition risks related to stricter climate change regulations and stakeholder preference for low-carbon products.

📋 Report Information

Reporting Period: 2023
Frameworks: GRI Standards, TCFD